SCHEMBL23439554

SCHEMBL23439554

CCCC(C)(C)OC(=O)N1CCC2(CC1)CCN(c1cccc(OC)c1)C2

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 15/20 0.48
HSD17B10 Q99714 9/20 0.48
USP2 O75604 12/20 0.48
TSHR P16473 7/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
FFAR4 Q5NUL3 1/20 0.48
ALDH1A1 P00352 10/20 0.47
MAPK1 P28482 9/20 0.47
HPGD P15428 3/20 0.47
HIF1A Q16665 3/20 0.47
CYP1A2 P05177 9/20 0.46
CYP2C19 P33261 9/20 0.46
CYP2C9 P11712 5/20 0.46
HBB P68871 2/20 0.46
SMN1; SMN2 Q16637 6/20 0.45
CYP2D6 P10635 1/20 0.44
ALOX15 P16050 1/20 0.44
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23440345 0.89 CTSB (0.51) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL29933185 0.87 CYP3A4 (0.53) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23439900 0.87 CYP3A4 (0.56) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23411493 0.87 CYP3A4 (0.53) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23439605 0.81 DRD2 (0.56) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL18831899 0.81 USP2 (0.58) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23439556 0.79 CYP3A4 (0.58) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23411518 0.75 CYP3A4 (0.55) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23412152 0.73 CYP3A4 (0.64) CYP3A4HSD17B10USP2TSHRMEN1
SCHEMBL23411476 0.73 ADRB1 (0.64) CYP3A4HSD17B10USP2TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105116-A1 SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION BAYER AKTIENGESELLSCHAFT (DE) 2021-06-03 WO disclosed